Core Viewpoint - The company, Wuhan Huaneng Biological Technology Co., Ltd., has approved an investment plan for a synthetic biology manufacturing project in Xinjiang to meet market demand for its core products and enhance production capacity and efficiency [1] Investment Details - The total investment for the Xinjiang synthetic biology manufacturing project is set at 1 billion yuan, which will be financed through the company's own funds [1] - The project will be constructed in three phases: - Phase 1 will focus on building a production workshop for veterinary raw materials and supporting public engineering systems, along with a drying workshop for microbial residues - Phase 2 will involve adding new processing equipment to the existing workshop to expand production capacity - Phase 3 will see the construction of a new production line on reserved land to accommodate the production of new products [1]
回盛生物:拟10亿元投资建设新疆合成生物学智造项目